(2022) Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation Biomedicines, 2022 Oct 25;10(11):2696
could use GLP-1RA only with a dosing frequency of once or more a day (liraglutide or exenatide twice a day), whereas those in the study of Blonde et al
When a person does desire to stop the medication, it is ideal if they can wean off of it, rather than stop abruptly
Interestingly, metabolic disorders and elevated oxidative stress disturb the insulin-associated signaling within the ovary and can dysregulate the dynamics of the ovarian function through the impair the ovarian reserve, survival, and quality of the eggs [15]